{"pmid":32323399,"title":"Management of advanced melanoma in the COVID-19 era.","text":["Management of advanced melanoma in the COVID-19 era.","Dermatol Ther","Conforti, Claudio","Giuffrida, Roberta","Di Meo, Nicola","Zalaudek, Iris","32323399"],"journal":"Dermatol Ther","authors":["Conforti, Claudio","Giuffrida, Roberta","Di Meo, Nicola","Zalaudek, Iris"],"date":"2020-04-24T11:00:00Z","year":2020,"_id":"32323399","week":"202017|Apr 20 - Apr 26","doi":"10.1111/dth.13444","keywords":["covid-19","sars-cov-2","cancer","coronavirus","melanoma","skin cancer"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664895932762685441,"score":8.518259,"similar":[{"pmid":32330540,"title":"Management of hepatocellular carcinoma in the time of COVID-19.","text":["Management of hepatocellular carcinoma in the time of COVID-19.","Ann Oncol","Iavarone, Massimo","Sangiovanni, Angelo","Carrafiello, Gianpaolo","Rossi, Giorgio","Lampertico, Pietro","32330540"],"journal":"Ann Oncol","authors":["Iavarone, Massimo","Sangiovanni, Angelo","Carrafiello, Gianpaolo","Rossi, Giorgio","Lampertico, Pietro"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32330540","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.annonc.2020.04.007","keywords":["sars-cov-2","cancer","liver transplantation","systemic treatment"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664996914964201472,"score":60.370834},{"pmid":32292919,"pmcid":"PMC7151392","title":"The Novel Coronavirus Disease (COVID-19) Threat for Patients with Cardiovascular Disease and Cancer.","text":["The Novel Coronavirus Disease (COVID-19) Threat for Patients with Cardiovascular Disease and Cancer.","JACC CardioOncol","Ganatra, Sarju","Hammond, Sarah P","Nohria, Anju","32292919"],"journal":"JACC CardioOncol","authors":["Ganatra, Sarju","Hammond, Sarah P","Nohria, Anju"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32292919","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.jaccao.2020.03.001","keywords":["ace-2, angiotensin-converting enzyme 2","acei, angiotensin converting enzyme inhibitor","arb, angiotensin receptor blocker","cdc, centers for disease control","covid-19","cvd, cardiovascular disease","coronavirus","coronavirus disease 2019, covid-19","mers-cov, middle east respiratory syndrome coronavirus","sars-cov-2","sars-cov-2, severe acute respiratory syndrome coronavirus 2","who, world health organization","cancer","cardio-oncology","cardiovascular disease"],"source":"PubMed","topics":["Treatment","Mechanism","Diagnosis","Prevention"],"weight":1,"_version_":1664636192483704832,"score":56.21864},{"pmid":32269597,"pmcid":"PMC7134578","title":"Upheaval in cancer care during the COVID-19 outbreak.","text":["Upheaval in cancer care during the COVID-19 outbreak.","On Monday, 23 March 2020, Nigeria recorded its first mortality from the novel global COVID-19 outbreak. Before this, the country reported 36 confirmed cases (at the time of writing) and has discharged home two cases after weeks of care at a government-approved isolation centre in Lagos State. This first mortality was that of a 67-year-old man with a history of multiple myeloma, a type of blood cancer. He was undergoing chemotherapy and had just returned to Nigeria following medical treatment in the United Kingdom. The novel COVID-19 pandemic has grounded several global activities including the provision of health care services to people with chronic conditions such as cancer. Evidence from China suggests that cancer patients with COVID-19 infection are a vulnerable group, with a higher risk of severe illness resulting in intensive care unit admissions or death, particularly if they received chemotherapy or surgery. This letter is an attempt to suggest practicable interventions such as the use of existing digital health platforms to limit patients' and oncology professionals' physical interactions as a way of reducing the risk of COVID-19 infection transmission amongst cancer patients and oncologists, as well as outlining effective strategies to ensure that cancer care is not completely disrupted during the outbreak.","Ecancermedicalscience","Salako, Omolola","Okunade, Kehinde","Allsop, Matthew","Habeebu, Muhammedu","Toye, Mariam","Oluyede, Glory","Fagbenro, Gabriel","Salako, Babatunde","32269597"],"abstract":["On Monday, 23 March 2020, Nigeria recorded its first mortality from the novel global COVID-19 outbreak. Before this, the country reported 36 confirmed cases (at the time of writing) and has discharged home two cases after weeks of care at a government-approved isolation centre in Lagos State. This first mortality was that of a 67-year-old man with a history of multiple myeloma, a type of blood cancer. He was undergoing chemotherapy and had just returned to Nigeria following medical treatment in the United Kingdom. The novel COVID-19 pandemic has grounded several global activities including the provision of health care services to people with chronic conditions such as cancer. Evidence from China suggests that cancer patients with COVID-19 infection are a vulnerable group, with a higher risk of severe illness resulting in intensive care unit admissions or death, particularly if they received chemotherapy or surgery. This letter is an attempt to suggest practicable interventions such as the use of existing digital health platforms to limit patients' and oncology professionals' physical interactions as a way of reducing the risk of COVID-19 infection transmission amongst cancer patients and oncologists, as well as outlining effective strategies to ensure that cancer care is not completely disrupted during the outbreak."],"journal":"Ecancermedicalscience","authors":["Salako, Omolola","Okunade, Kehinde","Allsop, Matthew","Habeebu, Muhammedu","Toye, Mariam","Oluyede, Glory","Fagbenro, Gabriel","Salako, Babatunde"],"date":"2020-04-10T11:00:00Z","year":2020,"_id":"32269597","week":"202015|Apr 06 - Apr 12","doi":"10.3332/ecancer.2020.ed97","keywords":["covid-19","cancer","cancer treatment","coronavirus"],"source":"PubMed","topics":["Prevention"],"weight":1,"locations":["Lagos State","Nigeria","United Kingdom","China"],"countries":["Nigeria","China","United Kingdom"],"countries_codes":["NGA|Nigeria","CHN|China","GBR|United Kingdom"],"_version_":1664637315667984384,"score":51.204884},{"pmid":32329924,"title":"Potential Impact of the COVID-19 Pandemic on Financial Toxicity in Cancer Survivors.","text":["Potential Impact of the COVID-19 Pandemic on Financial Toxicity in Cancer Survivors.","BACKGROUND: In the context of COVID-19, cancer survivors represent a particularly vulnerable population that may be \"doubly hit\" both by costs of cancer treatment and financial strain imposed by the pandemic. METHODS: We performed a review of the literature pertaining to cancer, financial toxicity, and economic challenges. RESULTS: Multiple societies have put forth recommendations to modify delivery of cancer care in order to minimize patient exposure to the virus. Cancer survivors, especially patients with head and neck cancer, have been disproportionately affected by rising unemployment levels and economic recessions in the past, both of which are linked to higher cancer mortality. Patients who rely on employer-provided insurance and do not qualify for Medicaid may lose access to life-saving treatments. CONCLUSIONS: It is essential to implement interventions and policy changes in order to mitigate the effects of this pandemic but also to ensure this becomes a non-issue during the next one. This article is protected by copyright. All rights reserved.","Head Neck","Baddour, Khalil","Kudrick, Lauren D","Neopaney, Aakriti","Sabik, Lindsay M","Peddada, Shyamal D","Nilsen, Marci L","Johnson, Jonas T","Ferris, Robert L","Mady, Leila J","32329924"],"abstract":["BACKGROUND: In the context of COVID-19, cancer survivors represent a particularly vulnerable population that may be \"doubly hit\" both by costs of cancer treatment and financial strain imposed by the pandemic. METHODS: We performed a review of the literature pertaining to cancer, financial toxicity, and economic challenges. RESULTS: Multiple societies have put forth recommendations to modify delivery of cancer care in order to minimize patient exposure to the virus. Cancer survivors, especially patients with head and neck cancer, have been disproportionately affected by rising unemployment levels and economic recessions in the past, both of which are linked to higher cancer mortality. Patients who rely on employer-provided insurance and do not qualify for Medicaid may lose access to life-saving treatments. CONCLUSIONS: It is essential to implement interventions and policy changes in order to mitigate the effects of this pandemic but also to ensure this becomes a non-issue during the next one. This article is protected by copyright. All rights reserved."],"journal":"Head Neck","authors":["Baddour, Khalil","Kudrick, Lauren D","Neopaney, Aakriti","Sabik, Lindsay M","Peddada, Shyamal D","Nilsen, Marci L","Johnson, Jonas T","Ferris, Robert L","Mady, Leila J"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32329924","week":"202017|Apr 20 - Apr 26","doi":"10.1002/hed.26187","keywords":["covid-19","cancer","coronavirus","financial toxicity","head and neck"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664996915009290240,"score":51.14736},{"pmid":32240755,"pmcid":"PMC7165240","title":"Home Care for Cancer Patients During COVID-19 Pandemic: The Double Triage Protocol.","text":["Home Care for Cancer Patients During COVID-19 Pandemic: The Double Triage Protocol.","Patients with cancer have an increased risk of developing severe forms of coronavirus disease 2019, and patients with advanced cancer who are followed at home represent a particularly frail population. Although with substantial differences, the challenges that cancer care professionals have to face during a pandemic are quite similar to those posed by natural disasters. We have already managed the oncological home care service in L'Aquila (middle Italy) after the 2009 earthquake. With this letter, we want to share the procedures and tools that we have started using at the home care service of the Tuscany Tumor Association during the coronavirus disease 2019 pandemic.","J Pain Symptom Manage","Porzio, Giampiero","Cortellini, Alessio","Bruera, Eduardo","Verna, Lucilla","Ravoni, Giulio","Peris, Flaminia","Spinelli, Giuseppe","32240755"],"abstract":["Patients with cancer have an increased risk of developing severe forms of coronavirus disease 2019, and patients with advanced cancer who are followed at home represent a particularly frail population. Although with substantial differences, the challenges that cancer care professionals have to face during a pandemic are quite similar to those posed by natural disasters. We have already managed the oncological home care service in L'Aquila (middle Italy) after the 2009 earthquake. With this letter, we want to share the procedures and tools that we have started using at the home care service of the Tuscany Tumor Association during the coronavirus disease 2019 pandemic."],"journal":"J Pain Symptom Manage","authors":["Porzio, Giampiero","Cortellini, Alessio","Bruera, Eduardo","Verna, Lucilla","Ravoni, Giulio","Peris, Flaminia","Spinelli, Giuseppe"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32240755","week":"202014|Mar 30 - Apr 05","doi":"10.1016/j.jpainsymman.2020.03.021","keywords":["covid-19","cancer","coronavirus","home care","palliative care"],"source":"PubMed","topics":["Prevention"],"weight":1,"locations":["L'Aquila"],"_version_":1664638354274123776,"score":51.131786}]}